Gastroenterology

Stool DNA test helps detect precancerous lesions in average-risk CRC population

Using a multitarget stool DNA test helped improve the sensitivity for detecting precancerous colorectal lesions compared with fecal immunochemical tests alone in an average-risk population, according to study results.
Gerrit A. Meijer, MD, PhD, of the department of pathology at the Netherlands Cancer Institute, and colleagues wrote that early detection of colorectal cancer and precancerous lesions is critical, and the accuracy of screening tests is an important determining factor in the success of screening programs.
“Based on extensive cost-effectiveness evaluation, many organized

Source link

Related posts

Does Aspirin Prophylaxis Reduce Mortality Risk Among Seniors?

Newsemia

Hepatocellular carcinoma is the most common liver-related complication in patients with histopathologically-confirmed NAFLD in Japan

Newsemia

ProSciento forms NASH Roundtable of experts to guide clinical research

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World